EI
MDXG icon

EAM Investors’s MiMedx Group MDXG Stock Holding History

EAM Investors’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-73,503
Closed -$645K – 299
2023
Q4 		$645K Sell
73,503
-590,710
-89% -$4.33M 0.11% 205
2023
Q3 		$4.84M Buy
664,213
+114,880
+21% +$856K 0.93% 4
2023
Q2 		$3.63M Buy
+549,333
New +$2.8M 0.67% 22
2021
Q3 		– Sell
-116,075
Closed -$1.45M – 346
2021
Q2 		$1.45M Buy
+116,075
New +$1.26M 0.22% 234
2017
Q3 		– Sell
-153,957
Closed -$2.31M – 320
2017
Q2 		$2.31M Buy
+153,957
New +$2.05M 0.38% 134
2015
Q1 		– Sell
-117,306
Closed -$1.35M – 368
2014
Q4 		$1.35M Buy
+117,306
New +$1.16M 0.19% 238
2013
Q3 		– Sell
-255,123
Closed -$1.8M – 345
2013
Q2 		$1.8M Buy
+255,123
New +$1.78M 0.39% 70

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM Investors's MDXG Position: Q1 2024 in Review

EAM Investors sold out of MiMedx Group (MDXG) in Q1 2024, closing a stake of 73,503 shares — an estimated $645K sold.

EAM Investors first reported a position in MDXG in Q2 2013 and held it in 7 quarters. The position peaked at $4.84M in Q3 2023. 202 funds tracked by Wall St. Rank hold MDXG as of Q1 2024.

  • EAM Investors reported no remaining MiMedx Group position as of Q1 2024 after selling out during the quarter.
  • EAM Investors sold 73,503 MiMedx Group shares in Q1 2024, an estimated $645K.
  • EAM Investors first reported a position in MiMedx Group in Q2 2013 and held it in 7 quarters.
  • EAM Investors's MiMedx Group position peaked at $4.84M in Q3 2023.
  • 202 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2024.

Based on EAM Investors's 13F filing for Q1 2024, filed 13 May 2024.